Urinary bother, Urinalysis, and Two-Year Efficacy Follow-Up Results of Phase I Trial of Intravesical Bacillus Calmette-Guérin Combined with Intravenous Pembrolizumab in Recurrent or Persistent High-Grade Non-Muscle-Invasive Bladder Cancer after Previous Bacillus Calmette-Guérin Treatment
-
Published:2024-06
Issue:3
Volume:22
Page:102059
-
ISSN:1558-7673
-
Container-title:Clinical Genitourinary Cancer
-
language:en
-
Short-container-title:Clinical Genitourinary Cancer
Author:
Montgomery JazzmyneORCID,
Lybbert Daniel,
Sana Sherjeel,
El-Zawahry AhmedORCID,
Peabody James,
Pearce Tiffany,
Adams Nicole,
Deebajah Mustafa,
Dynda Danuta,
Babaian Kara,
Crabtree Jane,
Delfino KristinORCID,
McVary Kevin,
Robinson KathyORCID,
Rao Krishna,
Alanee Shaheen
Funder
Henry Ford Health System
Merck & Co Inc
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献